Bg pattern

GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Galliad 0.74-1.85 GBq Radionuclide Generator

Gallium (68Ga) chloride solution

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your nuclear medicine doctor who will be supervising the procedure.
  • If you experience any side effects, talk to your nuclear medicine doctor, even if they are not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Galliad and what is it used for
  2. What you need to know before you start using the gallium (68Ga) chloride solution obtained with Galliad
  3. How to use the gallium (68Ga) chloride solution obtained with Galliad
  4. Possible side effects
  5. Storage of Galliad
  6. Package Contents and Further Information

1. What is Galliad and what is it used for

This medicine is a radiopharmaceutical that is not intended for direct use in patients.

Galliad is a germanium (68Ge) / gallium (68Ga) radionuclide generator, a device used to obtain a gallium (68Ga) chloride solution.

The gallium (68Ga) chloride solution obtained is used for radiolabeling, a technique that involves labeling a substance with a radioactive compound, in this case 68Ga.

Galliad is used to label certain medicines that have been developed and approved specifically for use with the active ingredient, gallium (68Ga) chloride. These medicines act as carriers to transport the radioactive 68Ga to where it is needed. This may involve substances designed to recognize a specific type of cell in the body, such as cancer cells. The small amount of radioactivity administered can be detected outside the body using special cameras.

Refer to the package leaflet of the medicine that will be radiolabeled with gallium (68Ga) chloride. Your nuclear medicine doctor will explain what kind of examination will be performed with this product.

Administration of a medicine labeled with 68Ga involves receiving small amounts of radioactivity. Your doctor and nuclear medicine doctor have considered that the clinical benefit you will gain from the procedure with the radiopharmaceutical outweighs the risk of radiation.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using the gallium (68Ga) chloride solution obtained with Galliad

The gallium (68Ga) chloride solution obtained with Galliad must not be used:

  • if you are allergic to gallium (68Ga) chloride or any of the other components of this medicine (listed in section 6).

If you are using a medicine labeled with 68Ga, you should read the information on contraindications in the package leaflet of the product that will be radiolabeled.

Warnings and Precautions

For information on warnings and precautions for the use of medicines labeled with 68Ga, refer to the package leaflet of the medicine that will be radiolabeled.

Children and Adolescents

Tell your nuclear medicine doctor if you or your child is under 18 years old.

Use of the gallium (68Ga) chloride solution obtained with Galliad with other medicines

Tell your nuclear medicine doctor if you are taking, have recently taken, or might take any other medicines, as some medicines may interfere with the interpretation of the images.

It is not known whether gallium (68Ga) chloride can interact with other medicines, as specific studies have not been conducted.

For more information on interactions associated with the use of medicines labeled with 68Ga, refer to the package leaflet of the medicine that will be radiolabeled.

Pregnancy, Breast-feeding, and Fertility

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your nuclear medicine doctor for advice before you are given medicines labeled with Galliad.

You should inform your nuclear medicine doctor before administration of medicines labeled with Galliad if there is any possibility that you may be pregnant, if you have missed a menstrual period, or if you are breast-feeding.

In case of doubt, it is important that you consult your nuclear medicine doctor who will be supervising the procedure.

If you are pregnant

Your nuclear medicine doctor will only give you this product during pregnancy if he/she anticipates that the benefit will outweigh the risks.

If you are breast-feeding

You will be asked to interrupt breast-feeding. Ask your nuclear medicine doctor when you can restart breast-feeding.

Driving and Using Machines

Your ability to drive and use machines may be affected due to the medicine used in combination with Galliad. Read the package leaflet of that medicine carefully.

3. How to use the gallium (68Ga) chloride solution obtained with Galliad

There are strict rules for the use, handling, and disposal of radiopharmaceuticals. Galliad will only be used in special controlled areas. This product will only be handled and administered by trained and qualified personnel who are authorized to use it safely. These individuals will take special care to use this product safely and will keep you informed of their actions.

The nuclear medicine doctor supervising the procedure will decide the amount of medicine labeled with Galliad to be used in your case. This will be the smallest amount necessary to achieve the desired result, depending on the medicine to be labeled and its intended use. For more information, read the package leaflet of the medicine that will be radiolabeled.

Administration of the gallium (68Ga) chloride solution obtained with Galliad and performance of the procedure

You will not receive the gallium (68Ga) chloride solution as such, but another product labeled with Galliad.

The gallium (68Ga) chloride solution should only be used in combination with another medicine that has been specifically developed for combination (radiolabeling) with Galliad. You will only receive the final labeled product.

Duration of the procedure

Your nuclear medicine doctor will inform you about the usual duration of the procedure after administration of the medicine labeled with Galliad.

After administration of the medicine labeled with Galliad

Your nuclear medicine doctor will inform you if you need to take any special precautions after receiving the medicine labeled with Galliad. Ask your nuclear medicine doctor if you have any questions.

If you have been given more medicine labeled with Galliad than you should

Overdose is unlikely since you will only receive the medicine labeled with Galliad under the precise control of the nuclear medicine doctor supervising the procedure. Nevertheless, in case of overdose, you will receive appropriate treatment.

If you have any further questions on the use of this product, ask your nuclear medicine doctor who will be supervising the procedure.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medicines, the medicine labeled with Galliad can cause side effects, although not everybody gets them.

Administration of the medicine labeled with Galliad involves receiving a small amount of ionizing radiation with a very low risk of developing cancer and genetic abnormalities.

Reporting of Side Effects

If you experience any side effects, talk to your nuclear medicine doctor, even if they are not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Agency: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Galliad

You will not need to store this medicine. This medicine is stored under the responsibility of a specialist in suitable premises. The storage of radiopharmaceuticals will be carried out in accordance with national regulations on radioactive materials.

The following information is intended for healthcare professionals only:

The radionuclide generator must not be used after the expiry date stated on the packaging after "EXP".

Do not dismantle the plastic casing. Do not store above 25°C.

The gallium (68Ga) chloride solution obtained with Galliad should be used immediately.

6. Package Contents and Further Information

Contents of Galliad

The active substance is gallium (68Ga) chloride solution.

The other ingredients are:

  • titanium dioxide (matrix).
  • hydrochloric acid 0.1 N sterile (elution solution).

Appearance of Galliad and Package Contents

You will not receive or handle this medicine.

Marketing Authorization Holder and Manufacturer

IRE-Elit

Avenue de l'Espérance

B-6220 Fleurus

Belgium

This medicine is authorized in the Member States of the European Economic Area under the following names:

Country

Product Name

Austria

Galli Ad 0.74-1.85 GBq, Radionuklidgenerator

Belgium

Galli Ad 0.74-1.85 GBq, radionuclidegenerator / générateur radiopharmaceutique / Radionuklidgenerator/

Denmark

Galli Ad 0.74-1.85 GBq, radionuklidgenerator

Finland

Galliad 0.74-1.85 GBq, radionuklidgeneraattori / radionuklidgenerator

France

Galliad 0.74-1.85 GBq, générateur radiopharmaceutique

Germany

Galli Ad 0.74-1.85 GBq, Radionuklidgenerator

Italy

Germanium chloride (68Ge)/Gallium chloride (68Ga) IRE-ELiT

Netherlands

GalliAd 0.74-1.85 GBq, radionuclidegenerator

Norway

Galliad

Luxembourg

Galli Ad 0.74-1.85 GBq, générateur radiopharmaceutique

Spain

Galliad 0.74-1.85 GBq radionuclide generator

Sweden

Galliad 0.74-1.85 GBq, radionuklidgenerator

United Kingdom

GalliAd 0.74-1.85 GBq, radionuclide generator

Date of last revision of this leaflet: May 2018

-----------------------------------------------------------------------------------------------------------------

This information is intended for healthcare professionals only:

The full summary of product characteristics of Galliad 0.74-1.85 GBq radionuclide generator is provided in a separate document in the product packaging, with the aim of providing healthcare professionals with additional scientific and practical information on the administration and use of this radiopharmaceutical.

Please refer to the summary of product characteristics.

Online doctors for GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR

Discuss questions about GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR?
GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR?
GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR is manufactured by Ire Elit. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to GALLIAD 0.74 - 1.85 GBq RADIOPHARMACEUTICAL GENERATOR?
Other medicines with the same active substance () include GALLIAPHARM 0.74 - 1.85 GBq RADIONUCLIDE GENERATOR, NORCOLESTEROL IODINATED (131 I) CIS BIO INTERNATIONAL 7.5-15 MBq/ml INJECTABLE SOLUTION, ADREVIEW 74 MBq/ml INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media